| | Authors reference | ANuA in SLE cohort
sensitivity/specificity () | % anti-dsDNA in SLE cohort | ANuA clinical and serological associations |
| | Sardeto et al., 2012 [88] | 62/100 (92) | 40 | Disease activity, anti-dsDNA | | Suleiman et al., 2009 [89] | 52/98 (90) | 37 | Disease activity, anti-DNA | | Kim et al., 2008 [95] | 98/78 (100) | nr | Leucopenia, low complement, disease activity, anti-dsDNA | | Bossuyt et al., 2008 [103] | 78/73 (40) | 65 | Proteinuria, disease flare, ANuA but not anti-dsDNA found in TNF alpha inhibitor related ANA | | Grootscholten et al., 2007 [83] | 81/nr (52) (LSLN) | 96 | Disease activity but not disease course, LN, anti-histone, anti-C1q | | Su et al., 2007 [96] | 62/98 (233) | nr | Disease activity, malar rash, arthralgia, anti-dsDNA | |
Düzgün et al., 2007 [6] | 55/98 (131) | nr | Disease activity, LN, anti-dsDNA | | Tikly et al., 2007 [97] | 45/94 (86) | nr | Disease activity, discoid lupus/malar rash, anti-dsDNA, aCL | | Braun et al., 2007 [94] | 64/99 (78) | | Disease activity, anti-dsDNA, anti-C1q | | Campos et al., 2006 [110] | 53/98 (74) (JSLE) | 54 | Disease activity, malar rash, hemolytic anemia, low complement, anti-dsDNA | |
Simón et al., 2004 [85] | 100/97 (73) | 63 | LN, malar rash, arthritis, oral ulcers, pleuritis, disease activity, renal damage | | Ghirardello et al., 2004 [93] | 86/95 (101) | 69 | Hematological, anti-dsDNA | | Cairns et al., 2003 [28] | 64/99 (95) | nr | LN, hematological, anti-dsDNA | | Cervera et al., 2003 [29] | 69/92 (100) | nr | LN, anti-dsDNA | | Min et al., 2002 [26] | 76/98 (129) | 79 | Disease activity, low complement, anti-dsDNA | | Amoura et al., 2000 [27] | 72/90 (120) | nr | Disease activity, LN |
|
|
